These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 18384629

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Single nucleotide polymorphisms in the promoter region of the E-cadherin gene in gastric cancer: case-control study in a young Mexican population.
    Medina-Franco H, Ramos-De la Medina A, Vizcaino G, Medina-Franco JL.
    Ann Surg Oncol; 2007 Aug; 14(8):2246-9. PubMed ID: 17549573
    [Abstract] [Full Text] [Related]

  • 23. E-cadherin gene polymorphisms and haplotype associated with the occurrence of epithelial ovarian cancer in Chinese.
    Li Y, Liang J, Kang S, Dong Z, Wang N, Xing H, Zhou R, Li X, Zhao X.
    Gynecol Oncol; 2008 Feb; 108(2):409-14. PubMed ID: 18035404
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Haplotypes of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study.
    Zheng Y, Shen H, Sturgis EM, Wang LE, Shete S, Spitz MR, Wei Q.
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):640-5. PubMed ID: 12101111
    [Abstract] [Full Text] [Related]

  • 26. The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder.
    Sak SC, Barrett JH, Paul AB, Bishop DT, Kiltie AE.
    Br J Cancer; 2005 Jun 20; 92(12):2262-5. PubMed ID: 15886698
    [Abstract] [Full Text] [Related]

  • 27. Liver intestine-cadherin (CDH17) haplotype is associated with increased risk of hepatocellular carcinoma.
    Wang XQ, Luk JM, Garcia-Barcelo M, Miao X, Leung PP, Ho DW, Cheung ST, Lam BY, Cheung CK, Wong AS, Lau SS, So MT, Yu WC, Cai Q, Liu KS, Hui CK, Lau GK, Poon RT, Wong J, Fan ST.
    Clin Cancer Res; 2006 Sep 01; 12(17):5248-52. PubMed ID: 16951245
    [Abstract] [Full Text] [Related]

  • 28. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
    Ahirwar D, Mandhani A, Mittal RD.
    Arch Med Res; 2009 Feb 01; 40(2):97-102. PubMed ID: 19237018
    [Abstract] [Full Text] [Related]

  • 29. p53 genotypes and haplotypes associated with risk of breast cancer.
    Buyru N, Altinisik J, Demokan S, Dalay N.
    Cancer Detect Prev; 2007 Feb 01; 31(3):207-13. PubMed ID: 17574348
    [Abstract] [Full Text] [Related]

  • 30. Characterization of intron-1 haplotypes of the G protein beta 4 subunit gene--association with survival and progression in patients with urothelial bladder carcinoma.
    Riemann K, Struwe H, Eisenhardt A, Obermaier B, Schmid KW, Siffert W.
    Pharmacogenet Genomics; 2008 Nov 01; 18(11):999-1008. PubMed ID: 18815590
    [Abstract] [Full Text] [Related]

  • 31. [Association of single nucleotide polymorphisms of Axis inhibitor-2 gene rs224030, rs8081536, rs9913621 with Hirschsprung disease].
    Gao H, Zhang J, Wang W, Zhang Z, Huang Y, Zhang S.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec 01; 25(6):697-700. PubMed ID: 19065536
    [Abstract] [Full Text] [Related]

  • 32. Promoter polymorphism in the MS4A2 gene and asthma in the Indian population.
    Sharma S, Ghosh B.
    Int Arch Allergy Immunol; 2009 Dec 01; 149(3):208-18. PubMed ID: 19218813
    [Abstract] [Full Text] [Related]

  • 33. Possible correlation between polymorphism in the tumor necrosis factor-beta gene and the clinicopathological features of bladder cancer in Japanese patients.
    Nonomura N, Tokizane T, Nakayama M, Inoue H, Nishimura K, Muramatsu M, Okuyama A.
    Int J Urol; 2006 Jul 01; 13(7):971-6. PubMed ID: 16882065
    [Abstract] [Full Text] [Related]

  • 34. [Association between genetic polymorphism of UGT1A7 and susceptibility of bladder cancer].
    Liu J, Yang XM, Liu G, Chang LS, Zhang LR, Song DK.
    Zhonghua Yi Xue Za Zhi; 2009 Dec 01; 89(44):3122-5. PubMed ID: 20193274
    [Abstract] [Full Text] [Related]

  • 35. Influence of XPD and APE1 DNA repair gene polymorphism on bladder cancer susceptibility in north India.
    Gangwar R, Ahirwar D, Mandhani A, Mittal RD.
    Urology; 2009 Mar 01; 73(3):675-80. PubMed ID: 19041121
    [Abstract] [Full Text] [Related]

  • 36. Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control study.
    Asefi V, Mojtahedi Z, Khademi B, Naeimi S, Ghaderi A.
    J Laryngol Otol; 2009 Apr 01; 123(4):444-8. PubMed ID: 18940019
    [Abstract] [Full Text] [Related]

  • 37. Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer.
    Porter TR, Richards FM, Houlston RS, Evans DG, Jankowski JA, Macdonald F, Norbury G, Payne SJ, Fisher SA, Tomlinson I, Maher ER.
    Oncogene; 2002 Mar 14; 21(12):1928-33. PubMed ID: 11896626
    [Abstract] [Full Text] [Related]

  • 38. Promoter region -318 C/ T and -1661 A/G CTLA-4 single nucleotide polymorphisms and type 1 diabetes in North Indians.
    Baniasadi V, Narain N, Goswami R, Das SN.
    Tissue Antigens; 2006 May 14; 67(5):383-9. PubMed ID: 16671945
    [Abstract] [Full Text] [Related]

  • 39. Genotypes of N-acetyltransferase-2 and risk of bladder cancer: a case-control study.
    Filiadis IF, Georgiou I, Alamanos Y, Kranas V, Giannakopoulos X, Lolis D.
    J Urol; 1999 May 14; 161(5):1672-5. PubMed ID: 10210437
    [Abstract] [Full Text] [Related]

  • 40. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.
    Bialecka M, Kurzawski M, Klodowska-Duda G, Opala G, Tan EK, Drozdzik M.
    Pharmacogenet Genomics; 2008 Sep 14; 18(9):815-21. PubMed ID: 18698234
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.